About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		Nudt15em1Maska
endonuclease-mediated mutation 1, Masahiro Kawahara
MGI:7595847
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
 		Nudt15em1Maska/Nudt15em1Maska C57BL/6-Nudt15em1Maska MGI:7596100
ht2
 		Nudt15em1Maska/Nudt15+ C57BL/6-Nudt15em1Maska MGI:7596101


Genotype
MGI:7596100
hm1
Allelic
Composition		 Nudt15em1Maska/Nudt15em1Maska
Genetic
Background		 C57BL/6-Nudt15em1Maska
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nudt15em1Maska mutation (0 available); any Nudt15 mutation (9 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:285800 )
• median lifespan of 21-26 days or 15-21 days after 1 or 2 mg/kg mercaptopurine (MP) administration, respectively
• minimum 70 day survival after 0.2 mg/kg mercaptopurine (MP) administration

hematopoietic system
decreased bone marrow cell number ( J:285800 )
• reduced number of nucleated BM cells after 5 days of 5 mg/kg mercaptopurine (MP) administration
decreased neutrophil cell number ( J:285800 )
• after 14 days of 1 or 7 or 14 days of 2 mg/kg mercaptopurine (MP) administration
• normal after 70 days of 0.2 mg/kg mercaptopurine (MP) administration
decreased hematopoietic stem cell number ( J:285800 )
• after 5 days of 2 or 5 mg/kg mercaptopurine (MP) administration
pancytopenia ( J:285800 )
• after 14 days of 1 or 2 mg/kg mercaptopurine (MP) administration
decreased hematopoietic precursor cell number ( J:285800 )
• reduced after 5 days of 2 mg/kg mercaptopurine (MP) administration

immune system
decreased neutrophil cell number ( J:285800 )
• after 14 days of 1 or 7 or 14 days of 2 mg/kg mercaptopurine (MP) administration
• normal after 70 days of 0.2 mg/kg mercaptopurine (MP) administration

growth/size/body
growth/size/body region phenotype ( J:285800 )
N
• normal esophagus, stomach, intestines, liver, lungs, and kidneys after 5 days of 5 mg/kg mercaptopurine (MP) administration

Mouse Models of Human Disease
 DO ID OMIM ID(s) Ref(s)
leukopenia DOID:615 J:285800
neutropenia DOID:1227 J:285800
pancytopenia DOID:12450 J:285800




Genotype
MGI:7596101
ht2
Allelic
Composition		 Nudt15em1Maska/Nudt15+
Genetic
Background		 C57BL/6-Nudt15em1Maska
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nudt15em1Maska mutation (0 available); any Nudt15 mutation (9 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
hematopoietic system
decreased neutrophil cell number ( J:285800 )
• after 14 days of 1 or 2 mg/kg mercaptopurine (MP) administration
pancytopenia ( J:285800 )
• after 14 days of 1 or 2 mg/kg mercaptopurine (MP) administration

immune system
decreased neutrophil cell number ( J:285800 )
• after 14 days of 1 or 2 mg/kg mercaptopurine (MP) administration

mortality/aging
premature death ( J:285800 )
• median lifespan of 48-66 days or 30 days after 1 or 2 mg/kg mercaptopurine (MP) administration, respectively
• minimum 70 day survival after 0.2 mg/kg mercaptopurine (MP) administration

Mouse Models of Human Disease
 DO ID OMIM ID(s) Ref(s)
leukopenia DOID:615 J:285800
neutropenia DOID:1227 J:285800
pancytopenia DOID:12450 J:285800




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
04/30/2024
MGI 6.23 		The Jackson Laboratory